Fundraising Fox

Proveca

Manchester, GB · Founded 2010 · 79 employees on LinkedIn · 2 known investors

Proveca is a pharmaceutical company that develops and licenses age-appropriate, licensed medicines for children, focusing on paediatric unmet medical needs. Its current therapy areas are neurology and cardiology, targeting children with chronic conditions requiring long-term treatment.

BiotechHealthtech

Founders & leadership

Proveca was founded in 2010 by Simon Bryson.

SB
Simon BrysonFounder

Investors · 2

AlbionVCLondon
Catapult VenturesreportedSilicon Valley · $250K – $1.5M

In the news

Investing in Proveca. Pharmaceutical firm specialising in paediatric medicinesproveca.com · Nov 2021Proveca Charity Initiatives To Support Children's Charitiesproveca.com · Feb 2020Paediatric pharmaceutical company in £4m funding for drug launchthebusinessdesk.com · Mar 2017Proveca raises GBP4m led by Catapult Ventures - Private Equity Wireprivateequitywire.co.uk · Mar 2017Proveca Raises £4 Million Led By Catapult Ventures To Launch Children’s Drug Sialanar In Europe And Accelerate Children’s Medicines Pipeline - BioSpacebiospace.com · Mar 2017

Frequently asked questions

What does Proveca do?
Proveca is a pharmaceutical company that develops and licenses age-appropriate, licensed medicines for children, focusing on paediatric unmet medical needs. Its current therapy areas are neurology and cardiology, targeting children with chronic conditions requiring long-term treatment.
Who founded Proveca?
Proveca was founded by Simon Bryson in 2010.
Who are Proveca's investors?
Proveca's investors include AlbionVC, Catapult Ventures.
Where is Proveca headquartered?
Proveca is headquartered in Manchester, GB.